Literature DB >> 20228834

The good and evil of complement activation in HIV-1 infection.

Qigui Yu1, Richard Yu, Xuebin Qin.   

Abstract

The complement system, a key component of innate immunity, is a first-line defender against foreign pathogens such as HIV-1. The role of the complement system in HIV-1 pathogenesis appears to be multifaceted. Although the complement system plays critical roles in clearing and neutralizing HIV-1 virions, it also represents a critical factor for the spread and maintenance of the virus in the infected host. In addition, complement regulators such as human CD59 present in the envelope of HIV-1 prevent complement-mediated lysis of HIV-1. Some novel approaches are proposed to combat HIV-1 infection through the enhancement of antibody-dependent complement activity against HIV-1. In this paper, we will review these diverse roles of complement in HIV-1 infection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20228834      PMCID: PMC4002684          DOI: 10.1038/cmi.2010.8

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  148 in total

1.  Characterization of CD4-induced epitopes on the HIV type 1 gp120 envelope glycoprotein recognized by neutralizing human monoclonal antibodies.

Authors:  Shi-Hua Xiang; Najah Doka; Rabeéa K Choudhary; Joseph Sodroski; James E Robinson
Journal:  AIDS Res Hum Retroviruses       Date:  2002-11-01       Impact factor: 2.205

Review 2.  Humoral immunity to HIV-1: neutralization and beyond.

Authors:  M Huber; A Trkola
Journal:  J Intern Med       Date:  2007-07       Impact factor: 8.989

3.  Crystal structure of CD59: implications for molecular recognition of the complement proteins C8 and C9 in the membrane-attack complex.

Authors:  Yuxiang Huang; Alena Fedarovich; Stephen Tomlinson; Christopher Davies
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2007-05-15

4.  In vivo and in vitro escape from neutralizing antibodies 2G12, 2F5, and 4E10.

Authors:  Amapola Manrique; Peter Rusert; Beda Joos; Marek Fischer; Herbert Kuster; Christine Leemann; Barbara Niederöst; Rainer Weber; Gabriela Stiegler; Hermann Katinger; Huldrych F Günthard; Alexandra Trkola
Journal:  J Virol       Date:  2007-06-13       Impact factor: 5.103

5.  Biologic response of B lymphoma cells to anti-CD20 monoclonal antibody rituximab in vitro: CD55 and CD59 regulate complement-mediated cell lysis.

Authors:  J Golay; L Zaffaroni; T Vaccari; M Lazzari; G M Borleri; S Bernasconi; F Tedesco; A Rambaldi; M Introna
Journal:  Blood       Date:  2000-06-15       Impact factor: 22.113

6.  Herpes simplex virus 1 infected neuronal and skin cells differ in their susceptibility to complement attack.

Authors:  Riina Rautemaa; Tuula Helander; Seppo Meri
Journal:  Immunology       Date:  2002-07       Impact factor: 7.397

Review 7.  Live recombinant vectors for AIDS vaccine development.

Authors:  Rebecca Voltan; Marjorie Robert-Guroff
Journal:  Curr Mol Med       Date:  2003-05       Impact factor: 2.222

Review 8.  The role of complement in the mechanism of action of rituximab for B-cell lymphoma: implications for therapy.

Authors:  Xuhui Zhou; Weiguo Hu; Xuebin Qin
Journal:  Oncologist       Date:  2008-09-08

9.  Nonneutralizing antibodies binding to the surface glycoprotein of lymphocytic choriomeningitis virus reduce early virus spread.

Authors:  Lars Hangartner; Raphaël M Zellweger; Mattia Giobbi; Jacqueline Weber; Bruno Eschli; Kathy D McCoy; Nicola Harris; Mike Recher; Rolf M Zinkernagel; Hans Hengartner
Journal:  J Exp Med       Date:  2006-07-31       Impact factor: 14.307

Review 10.  Viral mimicry of the complement system.

Authors:  John Bernet; Jayati Mullick; Akhilesh K Singh; Arvind Sahu
Journal:  J Biosci       Date:  2003-04       Impact factor: 1.826

View more
  29 in total

1.  Removal of the tag from His-tagged ILYd4, a human CD59 inhibitor, significantly improves its physical properties and its activity.

Authors:  Lin Wu; Sanbao Su; Fengming Liu; Tao Xu; Xiaoxiao Wang; Yan Huang; Xinlu Sun; Xiaowen Ge; Ting Chen; Huixia Liu; Chun Wang; Michael Chorev; Ting Xu; Xuebin Qin
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

2.  BLT-humanized C57BL/6 Rag2-/-γc-/-CD47-/- mice are resistant to GVHD and develop B- and T-cell immunity to HIV infection.

Authors:  Kerry J Lavender; Wendy W Pang; Ronald J Messer; Amanda K Duley; Brent Race; Katie Phillips; Dana Scott; Karin E Peterson; Charles K Chan; Ulf Dittmer; Timothy Dudek; Todd M Allen; Irving L Weissman; Kim J Hasenkrug
Journal:  Blood       Date:  2013-09-10       Impact factor: 22.113

3.  The function of adipsin and C9 protein in the complement system in HIV-associated preeclampsia.

Authors:  Mikyle David; Jagidesa Moodley; Thajasvarie Naicker
Journal:  Arch Gynecol Obstet       Date:  2021-04-21       Impact factor: 2.344

4.  Plasma levels of soluble membrane attack complex are elevated despite viral suppression in HIV patients with poor immune reconstitution.

Authors:  T N Schein; T E Blackburn; S L Heath; S R Barnum
Journal:  Clin Exp Immunol       Date:  2019-09-08       Impact factor: 4.330

Review 5.  Complement and HIV-I infection/HIV-associated neurocognitive disorders.

Authors:  Fengming Liu; Shen Dai; Jennifer Gordon; Xuebin Qin
Journal:  J Neurovirol       Date:  2014-03-18       Impact factor: 2.643

Review 6.  Human poly- and cross-reactive anti-viral antibodies and their impact on protection and pathology.

Authors:  Lucile Warter; Ramapraba Appanna; Katja Fink
Journal:  Immunol Res       Date:  2012-09       Impact factor: 2.829

7.  Comprehensive Cross-Clade Characterization of Antibody-Mediated Recognition, Complement-Mediated Lysis, and Cell-Mediated Cytotoxicity of HIV-1 Envelope-Specific Antibodies toward Eradication of the HIV-1 Reservoir.

Authors:  Shariq Mujib; Jun Liu; A K M Nur-Ur Rahman; Jordan A Schwartz; Phil Bonner; Feng Yun Yue; Mario A Ostrowski
Journal:  J Virol       Date:  2017-07-27       Impact factor: 5.103

8.  Proteomic landscape of bronchoalveolar lavage fluid in human immunodeficiency virus infection.

Authors:  Elizabeth V Nguyen; Sina A Gharib; Kristina Crothers; Yu-Hua Chow; David R Park; David R Goodlett; Lynn M Schnapp
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-11-08       Impact factor: 5.464

9.  Effects of Well-Controlled HIV Infection on Complement Activation and Function.

Authors:  Alexandria E-B Rossheim; Tina D Cunningham; Pamela S Hair; Tushar Shah; Kenji M Cunnion; Stephanie B Troy
Journal:  J Acquir Immune Defic Syndr       Date:  2016-09-01       Impact factor: 3.731

10.  A systems biology examination of the human female genital tract shows compartmentalization of immune factor expression.

Authors:  Adam Burgener; Annelie Tjernlund; Tove Kaldensjo; Max Abou; Stuart McCorrister; Garrett R Westmacott; Kenzie Mogk; Emma Ambrose; Kristina Broliden; Blake Ball
Journal:  J Virol       Date:  2013-02-28       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.